tiprankstipranks
Aldeyra Therapeutics (ALDX)
NASDAQ:ALDX
Holding ALDX?
Track your performance easily

Aldeyra Therapeutics (ALDX) Financial Statements

1,546 Followers

Aldeyra Therapeutics Financial Overview

Aldeyra Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.753; its P/E ratio is -6.47; Aldeyra Therapeutics is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-0.11. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -15.11M$ -16.37M$ -7.58M$ -4.24M$ -7.65M
EBITDA$ -15.01M$ -16.10M$ -7.52M$ -4.17M$ -7.58M
Net Income Common Stockholders$ -15.11M$ -16.85M$ -8.08M$ -4.75M$ -8.19M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 84.62M$ 89.30M$ 80.55M$ 0.00$ 0.00
Total Assets$ 117.32M$ 126.04M$ 141.30M$ 148.33M$ 147.28M
Total Debt$ 15.61M$ 15.64M$ 15.66M$ 15.66M$ 16.18M
Net Debt$ -69.01M$ -73.67M$ -64.89M$ 15.66M$ 16.18M
Total Liabilities$ 32.22M$ 27.73M$ 27.88M$ 28.53M$ 24.27M
Stockholders Equity$ 85.10M$ 98.31M$ 113.42M$ 119.80M$ 123.01M
Cash Flow-
Free Cash Flow$ -7.97M$ -13.22M$ -9.97M$ 500.44K$ -8.02M
Operating Cash Flow$ -7.97M$ -13.22M$ -9.97M$ 500.44K$ -8.02M
Investing Cash Flow$ 5.26M$ -18.24M$ -30.38M--
Financing Cash Flow$ -197.39K-$ 18.19K$ -1.01M$ -315.76K
Currency in USD

Aldeyra Therapeutics Earnings and Revenue History

Aldeyra Therapeutics Debt to Assets

Aldeyra Therapeutics Cash Flow

Aldeyra Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis